Connect with us

Cannabis News

THC-Rich Cannabis Imports Approved For First Licensed Medical Cannabis Company Hikurangi In New Zealand

Andrew Taft

Published

on

THC-Rich Cannabis Imports Approved For First Licensed Medical Cannabis Company Hikurangi In New Zealand

Hikurangi Cannabis Company has made great strides since it was first launched. It already holds the position as the first medical cannabis company to be licensed in all of New Zealand, which is a major feat for a company that was only founded in 2017. They have been featured in major publications like The New York Times and BBC World Service, and they managed to raise another $7 million for the expansion of cannabis cultivation in research only two months ago. Now, they have another victory to add – Hikurangi has become the first company to have permission to bring in high-THC strains to the country.

The permission comes with an adjustment to the cannabis license, which was only recently changed to permit low-THC cannabis plants to be used, according to reports in December. So far, they have beaten other companies in their submission of the application and their approval.

With the new licensing status, there are 16 new strains that Hikurangi plans to cultivate – five that are rich in THC, four that are rich in CBD and low in THC, and the others will be around the same quality as the low-THC strains.

Despite speculation, the impending 2020 referendum for the legalization of adult-use cannabis has nothing to do with the imports, according to Hikurangi’s managing director, Manu Caddie. Caddie instead said that the newly rich THC strains are meant for consumers that have to deal with a lot of pain, while the strains that are heavy in CBD will be meant for sufferers of seizure disorders, like epilepsy.

The next plan on Caddie’s agenda is to work on relationships with other countries in Asia that have a flourishing cannabis industry, like Thailand. With these new relationships, Hikurangi will hopefully create enough connection to trade new seeds and medicines between the countries.

He said,

“Last week we saw the government in Thailand approve medical cannabis, the Philippines, Malaysia and South Korea are all shifting quickly, and others are following.”

Andrew is a full-time professional writer in Canada with over 8 years of esteemed experience. He is one of the best cannabis health researchers, polished legal investigators and active CBD news reporters we have at TOC. While being featured in hundreds of health, technology, science, and even bitcoin publications; Andrew's now on the frontline of the Canadian cannabis culture and will continue breaking down everything so easily your grandma can understand hemp and CBD.

Continue Reading
Ultimate CBD Guide

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

CBD News Updates

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational purposes only.

Got news? Email contact@timesofcbd.com